Zobrazeno 1 - 10
of 33
pro vyhledávání: '"стронция ранелат"'
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 5, Iss 2, Pp 18-21 (2016)
Aim. To study effect of the bone metabolism modulator strontium ranelate on bone mineral density (BMD) and to evaluate it pleiotropic effects on cardiovascular remodeling in women with postmenopausal osteoporosis (PO) and a arterial hypertension (HT)
Externí odkaz:
https://doaj.org/article/ba58f80b529d46a5aa1d77b64ca39ee6
Autor:
Cyrus Cooper, J-Y Reginster, R Chapurlat, C Christiansen, H Genant, N Bellamy, W Bensen, F Navarro, J Badurski, E Nasonov, X Chevalier, P N Sambrook
Publikováno v:
Научно-практическая ревматология, Vol 51, Iss 5, Pp 481-494 (2013)
Objective: The osteoporosis drug strontium ranelate dissociates bone remodelling processes. It also inhibits subchondral bone resorption and stimulates cartilage matrix formation in vitro. Exploratory studies in the osteoporosis trialsreport that str
Externí odkaz:
https://doaj.org/article/5214a5955cbd4af085c0b1d0c2fade43
Autor:
Aleksandr Ivanovich Dubikov
Publikováno v:
Современная ревматология, Vol 7, Iss 2, Pp 82-86 (2013)
Osteoarthrosis (OA) is one of the most common diseases in the elderly; nonetheless, its treatment calls for further investigation. Present views are changing on the pathophysiology of OA, the role of the subchondral bone (SB), and an interaction betw
Externí odkaz:
https://doaj.org/article/19967980f5404f55a8fedcfe8ba7a7d0
Publikováno v:
Современная ревматология, Vol 7, Iss 1, Pp 77-81 (2013)
To prevent disease progression in patients with osteoarthosis (OA) remains a challenging problem. Despite the proposed drug, non-drug, and surgical treatments for OA, there is a clinical need for medications that have a structure-modifying effect and
Externí odkaz:
https://doaj.org/article/004ef4d77c134c6da2873d4064f1f2cb
Autor:
George P. Lyritis
Publikováno v:
Остеопороз и остеопатии, Vol 15, Iss 3, Pp 41-44 (2012)
«Переломы широко распространены у пациентов с остеопорозом. По данным эпидемиологических исследований, частота возникновения перелом
Externí odkaz:
https://doaj.org/article/e58d25a1c02148c78fd39620c7749531
Autor:
E A Pyadushkina, K V Gerasimova, S V Goryainov, Vitaly Vladimirovich Omelyanovsky, M V Avksentyeva, I S Krysanov
Publikováno v:
Современная ревматология, Vol 6, Iss 4, Pp 89-96 (2012)
Objective: to make a pharmacoeconomic analysis of the use of oral (a 150-mg tablet once a month) and injectable (a solution for intravenous bolus injection of 3 mg in 3 ml once every 3 months) ibandronate in patients with postmenopausal osteoporosis
Externí odkaz:
https://doaj.org/article/133612481081496fa034b2b7e95c2653
Publikováno v:
Travmatologiâ i Ortopediâ Rossii, Vol 0, Iss 2, Pp 99-104 (2012)
Scientific literature analysis shows that osteoporotic bone fractures appear to be actual and socially significant problem of modern medicine. Patients’ treatment with this pathology should be complex and include osteoporosis pharmacotherapy. The p
Externí odkaz:
https://doaj.org/article/f746a3357a9c4f358f78a9c4f9b3998c
Autor:
Olga Borisovna Yershova
Publikováno v:
Современная ревматология, Vol 4, Iss 4, Pp 54-58 (2010)
The possibility of recovering the functional status is now considered as an integral part of the development of new treatment strategies for chronic diseases, including osteoporosis (OP). The possibility to optimize the treatment of OP, by exerting a
Externí odkaz:
https://doaj.org/article/08a87985f6e8452b960a31889747bd2c
Publikováno v:
Современная ревматология, Vol 4, Iss 3, Pp 63-66 (2010)
The paper gives the data of current studies, which suggest the dual mechanism of action of strontium ranelate on bone remodeling in postmenopausal osteoporosis (OP): the drug made bone rearrangement balance shift toward a predominance of the processe
Externí odkaz:
https://doaj.org/article/a5421950fa324e949e3546a97a58398d
Autor:
N. Yu. Khozyainova, V. M. Tsareva, M. S. Bezaltynnykh, T. V. Bruk, N. Y. Hozyainova, M. S. Bezaltynnih, T. V. Brak
Publikováno v:
Остеопороз и остеопатии, Vol 13, Iss 1, Pp 3-5 (2010)
The trial was aimed at studying the effects of the modulator of bone metabolism - strontium ranelate on the parameters of cardiovascular remodeling in women with postmenopausal osteoporosis (OP) and arterial hypertension (AH). This effect includes th
Externí odkaz:
https://doaj.org/article/98df8a2a63914c20b216a0376105ef8d